Catalyst Pharmaceuticals Inc (CPRX)

Days of sales outstanding (DSO)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Receivables turnover		7.44	7.25	7.08	7.68	20.52	20.54	17.78	14.57	21.28	20.16	20.17	21.45	19.89	20.13	17.71	17.20	9.71	7.20	4.03	1.79
DSO	days	49.05	50.34	51.56	47.53	17.79	17.77	20.53	25.06	17.15	18.11	18.10	17.02	18.35	18.14	20.61	21.22	37.59	50.70	90.63	204.40

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 7.44
= 49.05

The days of sales outstanding (DSO) for Catalyst Pharmaceuticals Inc have exhibited fluctuations over the periods presented. DSO is a measure of how well a company is managing its accounts receivable. A lower DSO indicates that the company is collecting payments from customers faster, while a higher DSO suggests delayed collections.

In the most recent period, the DSO was 49.05 days, indicating that, on average, the company takes approximately 49 days to collect payment from its customers. Compared to the previous quarter, the DSO increased slightly from 47.53 days, which may indicate a slight delay in collecting payments.

Looking further back, the trend in DSO reveals variability in the company's historical performance. In particular, there were significant fluctuations in DSO over the past few years, with the DSO reaching as high as 204.40 days in March 2019. This substantial increase in DSO in 2019 may suggest potential issues with accounts receivable management during that period.

Overall, analyzing DSO trends can provide insights into a company's efficiency in collecting payments and managing its cash flow. It is essential for Catalyst Pharmaceuticals Inc to monitor and effectively manage its DSO to ensure timely collections and optimize its working capital efficiency.